Fragrance container
Latest Eli Lilly and Company Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
Description
FIG. 1 is a perspective view of a fragrance container showing my new design;
FIG. 2 is a front elevational view;
FIG. 3 is a rear elevational view;
FIG. 4 is a view looking from the left of FIG. 2;
FIG. 5 is a view looking from the right of FIG. 2;
FIG. 6 is a top plan view;
FIG. 7 is a bottom plan view; and
FIG. 8 is a perspective view showing a modified form of my new design.
Referenced Cited
Patent History
Patent number: D284548
Type: Grant
Filed: Jan 30, 1984
Date of Patent: Jul 8, 1986
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Marc A. Rosen (New York, NY)
Primary Examiner: Robert C. Spangler
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/574,810
Type: Grant
Filed: Jan 30, 1984
Date of Patent: Jul 8, 1986
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventor: Marc A. Rosen (New York, NY)
Primary Examiner: Robert C. Spangler
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/574,810
Classifications
Current U.S. Class:
D/9377;
D/9367;
D/9435